Opiate and non-opiate aspects of morphine induced seizures.
The intraperitoneal administration of morphine hydrochloride at doses of 300 mg/kg produced analgesia, catalepsy, and electrographic spiking in rats that developed into electrographic seizure patterns after approximately 2.5 h. Whereas naltrexone (12 mg/kg) reversed analgesia and catalepsy, and diminished electrographic spiking, it precipitated electrographic seizure activity similar to that observed following intraperitoneal morphine alone. These seizures were accompanied by behavioral convulsions. No tolerance to these seizures developed with repeated paired administration of morphine and naltrexone or in morphine tolerant rats, but rather potentiation was observed. The epileptogenic effects were found to be potentiated in amygdaloid kindled rats, as well. It was concluded that morphine at these doses activates two different epileptogenic mechanisms, one mediated by opiate receptors, the other not. The possibility of the simultaneous activation of a morphine sensitive anticonvulsant mechanism is discussed.
D000679:Amygdala / Q000187:drug effects; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005071:Evoked Potentials / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007696:Kindling, Neurologic / Q000187:drug effects; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D009115:Muridae; D009271:Naltrexone / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects*; D012640:Seizures / Q000139:chemically induced*
D011957:Receptors, Opioid; D009271:Naltrexone; D009020:Morphine